SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 35.20-2.6%Nov 7 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject11/29/2000 1:17:32 PM
From: keokalani'nui  Read Replies (1) of 566
 
Troubled Rigel waddles into market
November turns out as one of year's worst months


By Steve Gelsi, CBS.MarketWatch.com
Last Update: 12:45 PM ET Nov 29, 2000

Newswatch
Latest Headlines
Get Alerted


NEW YORK (CBS.MW) -- Shares of Rigel Pharmaceuticals barely budged from their offering price Wednesday as the troubled initial public offering had its debut amid a calmer mood in the stock market.

The South San Francisco, Calif.-based biotech firm (RIGL: news, msgs) opened at $7.25 on the Nasdaq, close to its $7 price. After pricing at the bottom of its lowered $7 to $8 range, the stock traded flat in the aftermarket by midday at $7 on volume of 1 million shares.


(for the whole story):

www2.marketwatch.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext